Venture Capital
Overview
Venture Capital for Life Sciences and Healthcare
We connect innovators with capital. Cardiff Advisory bridges early-stage and growth investors with founders in biotechnology, digital health, and healthcare services.
Our approach aligns strategic capital with long-term value creation.
Venture Transactions
Advised
Across seed, Series A–C,
and strategic rounds.
Institutional & Corporate Investors Engaged
Including venture capital, private equity, and corporate partners.
Overview
Venture Capital for Life Sciences and Healthcare
We connect innovators with capital. Cardiff Advisory bridges early-stage and growth investors with founders in biotechnology, digital health, and healthcare services.
Our approach aligns strategic capital with long-term value creation.
Venture Transactions
Advised
Across seed, Series A–C,
and strategic rounds.
Institutional & Corporate Investors Engaged
Including venture capital, private equity, and corporate partners.
Services
1. Fundraising Strategy
Design investor-ready narratives and models that highlight scientific differentiation and financial potential.
4. Valuation & Financial Planning
Provide data-driven valuation support to guide pricing and investor engagement.
2. Investor Introductions
Leverage Cardiff’s network across VCs, family offices, and strategic investors to source aligned capital.
5. Exit Planning
Position venture-backed companies for future M&A or IPO outcomes.
3. Term Sheet Advisory
Negotiate terms that balance growth flexibility with founder control.
Services
1. Fundraising Strategy
Design investor-ready narratives and models that highlight scientific differentiation and financial potential.
4. Valuation & Financial Planning
Provide data-driven valuation support to guide pricing and investor engagement.
2. Investor Introductions
Leverage Cardiff’s network across VCs, family offices, and strategic investors to source aligned capital.
5. Exit Planning
Position venture-backed companies for future M&A or IPO outcomes.
3. Term Sheet Advisory
Negotiate terms that balance growth flexibility with founder control.
Case Studies
OncoPath AI
$20M Series A financing in precision oncology.
NeuroSpan
$30M Series B in neurotherapeutics.
AestheGen
$18M strategic investment from medtech corporate.
BioAxis
$50M growth financing led by global PE fund.
HealTech
$10M seed raise for AI-driven health platform.
DermAI
$15M Series
A financing.
CellRegen
$25M crossover round in regenerative medicine.
PharmaNova
$35M Series B with corporate
co-investment.
VitaCore
$12M Series A
capital advisory.
Case Studies
OncoPath AI
$20M Series A financing in precision oncology.
NeuroSpan
$30M Series B in neurotherapeutics.
AestheGen
$18M strategic investment from medtech corporate.
BioAxis
$50M growth financing led by global PE fund.
HealTech
$10M seed raise for AI-driven health platform.
DermAI
$15M Series
A financing.
CellRegen
$25M crossover round in regenerative medicine.
PharmaNova
$35M Series B with corporate
co-investment.
VitaCore
$12M Series A
capital advisory.
Partners
SVB Leerink Partners
Novo Holdings
OrbiMed
RA Capital
Oppenheimer
Catalent Ventures
Partners
SVB Leerink Partners
Novo Holdings
OrbiMed
RA Capital
Oppenheimer
Catalent Ventures
Insights
Investor sentiment favors platforms with clinical validation and capital efficiency.
Our insight: the best financings are structured with the next transaction—and the next milestone—in mind.
Insights
Investor sentiment favors platforms with clinical validation and capital efficiency.
Our insight: the best financings are structured with the next transaction—and the next milestone—in mind.
Connect
Looking to raise your next round or attract the right investor?
Cardiff Advisory provides the access, structure, and expertise to help life sciences founders secure smart capital that accelerates growth.
Connect
Connect With Cardiff Advisory
Looking to raise your next round or attract the right investor?
Cardiff Advisory provides the access, structure, and expertise to help life sciences founders secure smart capital that accelerates growth.